BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 15510243)

  • 21. Hot topics and landmark studies from the 43rd annual meeting of the American Society of Clinical Oncology.
    Puglisi F; Aprile G; Fasola G
    Anticancer Drugs; 2008 Feb; 19(2):221-33. PubMed ID: 18176120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene therapy in prostate cancer: past, present and future.
    Shirakawa T; Fujisawa M; Gotoh A
    Front Biosci; 2008 Jan; 13():2115-9. PubMed ID: 17981696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Updates of adjuvant therapy in pancreatic cancer: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Li J; Merl MY; Chabot J; Saif MW
    JOP; 2010 Jul; 11(4):310-2. PubMed ID: 20601799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel agents for the treatment of pancreatic adenocarcinoma: any light at the end of the tunnel? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Dimou AT; Syrigos KN; Saif MW
    JOP; 2010 Jul; 11(4):324-7. PubMed ID: 20601803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Updates in pancreatic neuroendocrine carcinoma. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Alsamarai S; Libutti SK; Saif MW
    JOP; 2010 Jul; 11(4):336-40. PubMed ID: 20601807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcome of pancreatic cancer patients with diabetes mellitus: is diabetes a poor prognostic factor? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Kang SP; Saif MW
    JOP; 2010 Jul; 11(4):334-5. PubMed ID: 20601806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Not Available].
    Andrieu S; Filleron T;
    Rev Epidemiol Sante Publique; 2019 May; 67 Suppl 3():S119. PubMed ID: 30955996
    [No Abstract]   [Full Text] [Related]  

  • 28. Perspectives on Geriatric Oncology Research presented at the 2018 American Society of Clinical Oncology Annual Meeting.
    Soto-Perez-de-Celis E; Loh KP
    J Geriatr Oncol; 2018 Sep; 9(5):419-422. PubMed ID: 30005981
    [No Abstract]   [Full Text] [Related]  

  • 29. Locally advanced pancreatic adenocarcinoma: are we making progress?. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Li J; Ng J; Allendorf J; Saif MW
    JOP; 2011 Jul; 12(4):347-50. PubMed ID: 21737893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Updates in locally advanced pancreatic cancer. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Chang BW; Siccion E; Saif MW
    JOP; 2010 Jul; 11(4):313-6. PubMed ID: 20601800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New frontiers in molecular oncology.
    Memo M; Vezzoni P; Spano P
    Mol Med Today; 1995 Aug; 1(5):212-3. PubMed ID: 17607882
    [No Abstract]   [Full Text] [Related]  

  • 32. The 41st Annual Meeting of the American Society of Clinical Oncology. Orlando, FL, USA, 13-17 May, 2005.
    Montemurro F; Valabrega G; Garetto L; Aliberti S; Grignani G; Ortega C; Leone F; Ponzone R; Aglietta M
    Expert Opin Pharmacother; 2005 Dec; 6(16):2907-21. PubMed ID: 16318441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abstracts of the 41st Annual Meeting of the American Society of Clinical Oncology (ASCO). May 13-17, 2005. Orlando, Florida, USA.
    J Clin Oncol; 2005 Jun; 23(16 Suppl Pt 1):1s-1087s. PubMed ID: 15957209
    [No Abstract]   [Full Text] [Related]  

  • 34. Abstracts of the 41st Annual Meeting of the American Society of Clinical Oncology (ASCO). May 13-17, 2005. Orlando, Florida, USA. (Part 2).
    J Clin Oncol; 2005 Jun; 23(16 Suppl Pt 2):1090s-1100s. PubMed ID: 15957210
    [No Abstract]   [Full Text] [Related]  

  • 35. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes.
    Guillem JG; Wood WC; Moley JF; Berchuck A; Karlan BY; Mutch DG; Gagel RF; Weitzel J; Morrow M; Weber BL; Giardiello F; Rodriguez-Bigas MA; Church J; Gruber S; Offit K; ;
    J Clin Oncol; 2006 Oct; 24(28):4642-60. PubMed ID: 17008706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel agents in the treatment of unresectable neuroendocrine tumors. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Oberstein PE; Saif MW
    JOP; 2011 Jul; 12(4):358-61. PubMed ID: 21737896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Publication outcomes of phase II oncology clinical trials.
    Hoeg RT; Lee JA; Mathiason MA; Rokkones K; Serck SL; Crampton KL; Emmel AE; Severson EA; Go RS
    Am J Clin Oncol; 2009 Jun; 32(3):253-7. PubMed ID: 19349853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. American Society of Gene Therapy--tenth annual meeting.
    Romano G; Giordano A
    IDrugs; 2007 Aug; 10(8):534-7. PubMed ID: 17665326
    [No Abstract]   [Full Text] [Related]  

  • 39. The ASCO annual meeting and excess baggage.
    Rosenthal M
    J Clin Oncol; 1999 Sep; 17(9):3005-6. PubMed ID: 10561382
    [No Abstract]   [Full Text] [Related]  

  • 40. Palliative care of pancreatic cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Saif MW
    JOP; 2011 Jul; 12(4):355-7. PubMed ID: 21737895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.